Skip to main content
. 2015 Jul 17;6(28):25988–26001. doi: 10.18632/oncotarget.4620

Figure 1. Inhibitory effects of bortezomib on the proliferation of human Burkitt's lymphoma cells.

Figure 1

A. Daudi and B. CA46 cells were treated with various concentrations of bortezomib for different periods, and the viable cells were determined by MTT assay. The data are presented as mean ± S.E. of three independent experiments.